SARASOTA, Fla. - July 23, 2013 (www.investorideas.com newswire) via PRWEB - MobileBits, (OTCBB: MBIT), provider of the SAMY(TM) mobile marketing and engagement network, today announced that it has released version 1.5 of its SAMY mobile application suite which includes updates for Apple iOS, availability for popular Android-based smartphones such as Samsung Galaxy, LG, HTC, Sony Ericsson and Motorola, a brand new Amazon Kindle app as well as support for BlackBerry 10 OS phones. SAMY 1.5 features a redesigned user interface for iOS, as well as an upgrade to the overall application features including faster loading times and responsiveness. It also includes new location functionality support for Android OS, which is now integrated with Google services enabling driving direction integration and seamless location service updates.

Read more: Mobile Commerce Stock Alert: MobileBit's (OTCBB: MBIT) Samy Gets New App Redesign for Apple iPhone...

Point Roberts, WA, New York, NY - July 22, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a trading alert for Aethlon Medical, Inc. (OTCQB: AEMD), The stock is trading at $0.13, gaining 0.0180 or 16.07% 10:30AM EDT on over 460,000 shares.

Last week Brian Marckx, CFA from Zacks Small Cap Research Issued an updated on the company entitled, “AEMD: Recent Progress Helps De-Risk Aethlon” and increased his price on the stock.

Read more: Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Gains 16%

Point Roberts, WA, New York, NY - July 19, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a research alert for Aethlon Medical, Inc. (OTCQB:AEMD), Yesterday Brian Marckx, CFA from Zacks Small Cap Research Issued an updated on the company entitled, “AEMD: Recent Progress Helps De-Risk Aethlon.” In his report he noted, “based on our DCF model AEMD is valued at about $0.15/share."

Read more: Research Alert: Zacks Small Cap Research Increases Price Target for Aethlon Medical (OTCQB:AEMD)

July 18, 2013 (Investorideas.com newswire) We have updated our report on Aethlon Medical (OTCBB:AEMD) for their 10-K filing as well as other recent events. See below for access to the full report.

10-K Filed for Fiscal 2013 (ending 3/31/2013)

Aethlon (AEMD) filed their 10-K for the fiscal year ending 3/31/2013 on July 15th. Results (excluding non-cash change in derivative liability expense) remain very much in-line with our estimates. AEMD booked $404k in DARPA contract revenue in Q4 compared to our $380k estimate. Revenue relates to the tenth and eleventh milestones under the DARPA contract (the second and third milestones under the year-2 contract). Subsequent to (in April 2013) the end of fiscal 2013 AEMD booked another $196k related to the twelfth milestone.

Read more: Medical Technology Stock Breaking News: Aethlon Medical (OTCQB: AEMD) Recent Progress Helps...

Point Roberts, WA, New York, NY - July 17, 2013 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, a research portal featuring investing ideas in leading sectors, issues a snapshot of India’s mobile payment market and news from Calpian, Inc. (OTCQB: CLPI ), a company in the mobile payments emerging-market through its subsidiary in India.

According to a report from Gartner in June, "Worldwide mobile payment transaction values will reach $235.4 billion in 2013, a 44 percent increase from 2012 values of $163.1 billion, according to Gartner, Inc. The number of mobile payment users worldwide will reach 245.2 million in 2013, up from 200.8 million in 2012.

Read more: Mobile Payments in India; Calpian's (OTCQB: CLPI) Indian Subsidiary Money-on-Mobile Grows to Serve...